Life ScienceCompany
Where is SanReno Therapeutics headquartered?
SanReno Therapeutics is headquartered in Shanghai, China.
What sector is SanReno Therapeutics in?
SanReno Therapeutics is a life science company.
SanReno Therapeutics is headquartered in Shanghai, China.
SanReno Therapeutics is a life science company.
Shanghai,
China,
400-883-0816
www.sanreno.com
SanReno Therapeutics is a clinical-stage enterprise specializing in the strategic development, exploration, and commercialization of revolutionary therapies tailored for kidney diseases. The company's key assets focus on treating Immunoglobulin A Nephropathy (IgAN). Atrasentan, an oral endothelian A receptor antagonist (ERA), has reached Phase 3 with success in reducing proteinuria. Zigakibart, its anti-APRIL (A Proliferation Inducing Ligand) antibody, received regulatory approval for Phase 3 studies. SanReno Therapeutics is based in Shanghai.
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.